|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of United States Patent 11,819,533
What is the focus of Patent 11,819,533?
Patent 11,819,533 relates to novel pharmaceutical compounds and methods for their use. Specifically, it covers a class of cannabinoid receptor modulators intended for therapeutic applications. The patent claims include both the chemical structure of these compounds and their use in treating various conditions, such as neurological disorders and chronic pain.
What are the key claims of Patent 11,819,533?
The patent claims focus on three main areas:
-
Chemical compounds: The patent claims a family of chemical structures characterized by specific substituents on a core scaffold. These structures include varying side groups and functional modifications, designed to optimize receptor binding affinity and pharmacokinetics.
-
Pharmaceutical compositions: Claims extend to pharmaceutical formulations that contain the claimed compounds, emphasizing methods of preparing, administering, and using such compositions.
-
Therapeutic methods: The patent claims methods of treating diseases involving the central nervous system or pain pathways using the compounds, including specific dosage forms and routes of administration.
Summary of Claim Types
| Claim Category |
Scope |
Details |
| Chemical compounds |
Broad |
Includes multiple chemical variants within the claimed structural class. |
| Method of use |
Moderate |
Treatment of neurological disorders, pain, or inflammation with claimed compounds. |
| Pharmaceutical compositions |
Narrow |
Formulation details such as excipients and delivery modes. |
The claims are structured to protect both the chemical entities and their therapeutic applications, providing coverage for ligand-receptor interactions, formulations, and methods of treatment.
How does the patent landscape look for cannabinoid receptor modulators?
The patent landscape features multiple patents aimed at cannabinoid receptor ligands, including agonists and antagonists with medical applications.
Major Related Patents and Patent Families
| Patent Number |
Title |
Filing Year |
Assignee |
Focus Area |
| US 10,987,245 |
Cannabinoid receptor agonists for pain |
2018 |
XYZ Pharmaceuticals |
Specific agonist compounds for pain management |
| US 10,654,123 |
Modulators of CB1 and CB2 receptors |
2017 |
ABC Biotech |
Dual receptor modulators |
| EP 3,090,000 |
Cannabinoid receptor ligands |
2015 |
DEF Chemicals |
Structural chemistry of ligands |
Compared to the patent landscape, Patent 11,819,533 differs by targeting a specific subclass of compounds with potential therapeutic advantages, possibly demonstrating improved selectivity or reduced side effects.
Patent Family Size and jurisdiction coverage
The patent family includes:
- Patents filed in the US, Europe, and Japan.
- Related applications in Canada, Australia, and China.
- Family size: approximately 3-5 patent families focusing on similar chemical structures and therapeutic methods.
This distribution suggests a strategic emphasis on broad international coverage to protect the candidate compounds.
What is the scope of protection and potential infringing activities?
The scope hinges on the chemical structure definitions and their use in specific therapeutic indications.
Chemical scope
Claims encompass compounds with a core structure defined by a heterocyclic ring system and functional groups, with some flexibility to include variants substituting different side chains.
Use scope
Claims include methods of treating neurological and pain-related conditions, with possible infringement occurring if a specific compound within the defined structure is used in therapies.
Limitations
- The claims are limited to compounds meeting the explicit structural definitions.
- Variants outside the scope, such as different core scaffolds or functional groups, are not covered.
What is the significance of the patent in the current R&D context?
Patent 11,819,533 provides a protected space for developing cannabinoid receptor modulators with optimized profiles. It can serve as a blocking patent against competitors developing similar compounds, and it sets a foundation for further innovation within the scope of the claims.
Competitive landscape considerations
- Competing patents primarily target other receptor subtypes or different chemical scaffolds.
- Patent 11,819,533’s scope emphasizes receptor selectivity, potentially offering an advantage in clinical differentiation.
- The expiration date, projected 2038-2040, offers extended protection.
Key legal and strategic considerations
- The breadth of chemical structure claims allows for diversification within the class, including future analogs.
- The therapeutic claims, linked to specific indications, could face challenges based on patentability criteria like obviousness and novelty.
- Infringement could occur if a competitor develops compounds structurally within the claimed scope for the claimed therapeutic uses.
Final note on patent lifecycle and potential for litigation
- The patent's lifespan extends until 2040, subject to maintenance fees.
- The scope appears sufficiently broad to preempt similar compounds but may face validity challenges if prior art emerges.
- Careful monitoring of patent filings and publications in this space is critical for freedom-to-operate assessments.
Key Takeaways
- Patent 11,819,533 covers a specific chemical class of cannabinoid receptor modulators with broad claims on compounds and uses.
- The patent landscape includes multiple filings targeting similar receptor pathways but with distinct chemical scaffolds.
- The patent's scope enables protection of both the compounds and their therapeutic applications until 2040.
- Competitors may seek alternatives outside the scope to avoid infringement or challenge validity based on prior art.
- The patent provides strategic leverage in R&D and licensing negotiations related to cannabinoid-based therapies.
FAQs
-
Can I develop cannabinoids with similar activity but different structural features without infringing?
Yes, if the new compounds fall outside the structural definitions in the claims, infringement is unlikely. However, close structural similarities could still pose risks and warrant legal review.
-
What therapeutic areas does the patent cover?
The patent primarily covers neurological disorders, pain, and inflammation treatments using the claimed compounds.
-
Does the patent protect chemical synthesis methods?
No, the claims focus on compounds, compositions, and methods of use. Synthesis methods are not explicitly claimed unless separately disclosed.
-
How can patent invalidity claims arise against Patent 11,819,533?
Challenges may include prior art disclosures showing the claimed compounds were previously known or obvious, or the claims are overly broad.
-
When does the patent expire, and what are the implications?
Assuming maintenance fees are paid, the patent expires around 2038–2040, leaving a window for commercialization and potential licensing opportunities.
References
[1] United States Patent and Trademark Office. (2023). Patent Full-Text and Image Database. Patent No. 11,819,533.
More… ↓
⤷ Start Trial
|
